Global Biosimilar Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Report ID: GIR2201090392 | Category: Pharma & Healthcare | Pages: 100 | Format: PDF | Published Date: November 07,2022

Request Sample Enquiry before buying Ask For Discount

Single User-$3480.00 Multi User-$5220.00

Report Description
View Table of Contents

Report Summary

The Biosimilar market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Biosimilar market size is estimated to be worth US$ 8650.9 million in 2021 and is forecast to a readjusted size of USD 22110 million by 2028 with a CAGR of 14.3% during review period. Hospital Pharmacy accounting for  % of the Biosimilar global market in 2021, is projected to value USD   million by 2028, growing at a  % CAGR in next six years. While Tablet segment is altered to a  % CAGR between 2022 and 2028.
Global key companies of Biosimilar include AET BioTech, Amgen, Boehringer Ingelheim, Coherus Biosciences, and Fujifilm Kyowa Kirin Biologics, etc. In terms of revenue, the global top four players hold a share over  % in 2021.
Market segmentation
Biosimilar market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
    Tablet
    Oral Solution
Market segment by Application, can be divided into
    Hospital Pharmacy
    Retail Pharmacy
    Online Pharmacy
Market segment by players, this report covers
    AET BioTech
    Amgen
    Boehringer Ingelheim
    Coherus Biosciences
    Fujifilm Kyowa Kirin Biologics
    LG Life Sciences/Mochida Pharmaceutical
    Momenta Pharmaceuticals
    Oncobiologics
    Pfizer
    Samsung Bioepsis
    Sandoz
    Zydus Cadila
Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
    South America (Brazil, Argentina, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Biosimilar product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Biosimilar, with revenue, gross margin and global market share of Biosimilar from 2019 to 2022.
Chapter 3, the Biosimilar competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Biosimilar market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Biosimilar research findings and conclusion, appendix and data source.

1 Market Overview
    1.1 Product Overview and Scope of Biosimilar
    1.2 Classification of Biosimilar by Type
        1.2.1 Overview: Global Biosimilar Market Size by Type: 2017 Versus 2021 Versus 2028
        1.2.2 Global Biosimilar Revenue Market Share by Type in 2021
        1.2.3 Tablet
        1.2.4 Oral Solution
    1.3 Global Biosimilar Market by Application
        1.3.1 Overview: Global Biosimilar Market Size by Application: 2017 Versus 2021 Versus 2028
        1.3.2 Hospital Pharmacy
        1.3.3 Retail Pharmacy
        1.3.4 Online Pharmacy
    1.4 Global Biosimilar Market Size & Forecast
    1.5 Global Biosimilar Market Size and Forecast by Region
        1.5.1 Global Biosimilar Market Size by Region: 2017 VS 2021 VS 2028
        1.5.2 Global Biosimilar Market Size by Region, (2017-2022)
        1.5.3 North America Biosimilar Market Size and Prospect (2017-2028)
        1.5.4 Europe Biosimilar Market Size and Prospect (2017-2028)
        1.5.5 Asia-Pacific Biosimilar Market Size and Prospect (2017-2028)
        1.5.6 South America Biosimilar Market Size and Prospect (2017-2028)
        1.5.7 Middle East and Africa Biosimilar Market Size and Prospect (2017-2028)
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Biosimilar Market Drivers
        1.6.2 Biosimilar Market Restraints
        1.6.3 Biosimilar Trends Analysis
2 Company Profiles
    2.1 AET BioTech
        2.1.1 AET BioTech Details
        2.1.2 AET BioTech Major Business
        2.1.3 AET BioTech Biosimilar Product and Solutions
        2.1.4 AET BioTech Biosimilar Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.1.5 AET BioTech Recent Developments and Future Plans
    2.2 Amgen
        2.2.1 Amgen Details
        2.2.2 Amgen Major Business
        2.2.3 Amgen Biosimilar Product and Solutions
        2.2.4 Amgen Biosimilar Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.2.5 Amgen Recent Developments and Future Plans
    2.3 Boehringer Ingelheim
        2.3.1 Boehringer Ingelheim Details
        2.3.2 Boehringer Ingelheim Major Business
        2.3.3 Boehringer Ingelheim Biosimilar Product and Solutions
        2.3.4 Boehringer Ingelheim Biosimilar Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.3.5 Boehringer Ingelheim Recent Developments and Future Plans
    2.4 Coherus Biosciences
        2.4.1 Coherus Biosciences Details
        2.4.2 Coherus Biosciences Major Business
        2.4.3 Coherus Biosciences Biosimilar Product and Solutions
        2.4.4 Coherus Biosciences Biosimilar Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.4.5 Coherus Biosciences Recent Developments and Future Plans
    2.5 Fujifilm Kyowa Kirin Biologics
        2.5.1 Fujifilm Kyowa Kirin Biologics Details
        2.5.2 Fujifilm Kyowa Kirin Biologics Major Business
        2.5.3 Fujifilm Kyowa Kirin Biologics Biosimilar Product and Solutions
        2.5.4 Fujifilm Kyowa Kirin Biologics Biosimilar Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.5.5 Fujifilm Kyowa Kirin Biologics Recent Developments and Future Plans
    2.6 LG Life Sciences/Mochida Pharmaceutical
        2.6.1 LG Life Sciences/Mochida Pharmaceutical Details
        2.6.2 LG Life Sciences/Mochida Pharmaceutical Major Business
        2.6.3 LG Life Sciences/Mochida Pharmaceutical Biosimilar Product and Solutions
        2.6.4 LG Life Sciences/Mochida Pharmaceutical Biosimilar Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.6.5 LG Life Sciences/Mochida Pharmaceutical Recent Developments and Future Plans
    2.7 Momenta Pharmaceuticals
        2.7.1 Momenta Pharmaceuticals Details
        2.7.2 Momenta Pharmaceuticals Major Business
        2.7.3 Momenta Pharmaceuticals Biosimilar Product and Solutions
        2.7.4 Momenta Pharmaceuticals Biosimilar Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.7.5 Momenta Pharmaceuticals Recent Developments and Future Plans
    2.8 Oncobiologics
        2.8.1 Oncobiologics Details
        2.8.2 Oncobiologics Major Business
        2.8.3 Oncobiologics Biosimilar Product and Solutions
        2.8.4 Oncobiologics Biosimilar Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.8.5 Oncobiologics Recent Developments and Future Plans
    2.9 Pfizer
        2.9.1 Pfizer Details
        2.9.2 Pfizer Major Business
        2.9.3 Pfizer Biosimilar Product and Solutions
        2.9.4 Pfizer Biosimilar Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.9.5 Pfizer Recent Developments and Future Plans
    2.10 Samsung Bioepsis 
        2.10.1 Samsung Bioepsis Details
        2.10.2 Samsung Bioepsis Major Business
        2.10.3 Samsung Bioepsis Biosimilar Product and Solutions
        2.10.4 Samsung Bioepsis Biosimilar Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.10.5 Samsung Bioepsis Recent Developments and Future Plans
    2.11 Sandoz
        2.11.1 Sandoz Details
        2.11.2 Sandoz Major Business
        2.11.3 Sandoz Biosimilar Product and Solutions
        2.11.4 Sandoz Biosimilar Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.11.5 Sandoz Recent Developments and Future Plans
    2.12 Zydus Cadila
        2.12.1 Zydus Cadila Details
        2.12.2 Zydus Cadila Major Business
        2.12.3 Zydus Cadila Biosimilar Product and Solutions
        2.12.4 Zydus Cadila Biosimilar Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.12.5 Zydus Cadila Recent Developments and Future Plans
3 Market Competition, by Players
    3.1 Global Biosimilar Revenue and Share by Players (2019, 2020, 2021, and 2022)
    3.2 Market Concentration Rate
        3.2.1 Top 3 Biosimilar Players Market Share in 2021
        3.2.2 Top 10 Biosimilar Players Market Share in 2021
        3.2.3 Market Competition Trend
    3.3 Biosimilar Players Head Office, Products and Services Provided
    3.4 Biosimilar Mergers & Acquisitions
    3.5 Biosimilar New Entrants and Expansion Plans
4 Market Size Segment by Type
    4.1 Global Biosimilar Revenue and Market Share by Type (2017-2022)
    4.2 Global Biosimilar Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
    5.1 Global Biosimilar Revenue Market Share by Application (2017-2022)
    5.2 Global Biosimilar Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
    6.1 North America Biosimilar Revenue by Type (2017-2028)
    6.2 North America Biosimilar Revenue by Application (2017-2028)
    6.3 North America Biosimilar Market Size by Country
        6.3.1 North America Biosimilar Revenue by Country (2017-2028)
        6.3.2 United States Biosimilar Market Size and Forecast (2017-2028)
        6.3.3 Canada Biosimilar Market Size and Forecast (2017-2028)
        6.3.4 Mexico Biosimilar Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
    7.1 Europe Biosimilar Revenue by Type (2017-2028)
    7.2 Europe Biosimilar Revenue by Application (2017-2028)
    7.3 Europe Biosimilar Market Size by Country
        7.3.1 Europe Biosimilar Revenue by Country (2017-2028)
        7.3.2 Germany Biosimilar Market Size and Forecast (2017-2028)
        7.3.3 France Biosimilar Market Size and Forecast (2017-2028)
        7.3.4 United Kingdom Biosimilar Market Size and Forecast (2017-2028)
        7.3.5 Russia Biosimilar Market Size and Forecast (2017-2028)
        7.3.6 Italy Biosimilar Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
    8.1 Asia-Pacific Biosimilar Revenue by Type (2017-2028)
    8.2 Asia-Pacific Biosimilar Revenue by Application (2017-2028)
    8.3 Asia-Pacific Biosimilar Market Size by Region
        8.3.1 Asia-Pacific Biosimilar Revenue by Region (2017-2028)
        8.3.2 China Biosimilar Market Size and Forecast (2017-2028)
        8.3.3 Japan Biosimilar Market Size and Forecast (2017-2028)
        8.3.4 South Korea Biosimilar Market Size and Forecast (2017-2028)
        8.3.5 India Biosimilar Market Size and Forecast (2017-2028)
        8.3.6 Southeast Asia Biosimilar Market Size and Forecast (2017-2028)
        8.3.7 Australia Biosimilar Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
    9.1 South America Biosimilar Revenue by Type (2017-2028)
    9.2 South America Biosimilar Revenue by Application (2017-2028)
    9.3 South America Biosimilar Market Size by Country
        9.3.1 South America Biosimilar Revenue by Country (2017-2028)
        9.3.2 Brazil Biosimilar Market Size and Forecast (2017-2028)
        9.3.3 Argentina Biosimilar Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
    10.1 Middle East & Africa Biosimilar Revenue by Type (2017-2028)
    10.2 Middle East & Africa Biosimilar Revenue by Application (2017-2028)
    10.3 Middle East & Africa Biosimilar Market Size by Country
        10.3.1 Middle East & Africa Biosimilar Revenue by Country (2017-2028)
        10.3.2 Turkey Biosimilar Market Size and Forecast (2017-2028)
        10.3.3 Saudi Arabia Biosimilar Market Size and Forecast (2017-2028)
        10.3.4 UAE Biosimilar Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
    12.1 Methodology
    12.2 Research Process and Data Source
    12.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Global Biosimilar Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?